Screener
Viking Therapeutics VKTX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Viking Therapeutics’s 10-Q, filed April 30, 2026.
- Filed
- Apr 29, 2026, 9:50 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-193315
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.00001 par value: 10,000,000 shares authorized at March 31, 2026 and December 31, 2025; no shares issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.00001 par value: 300,000,000 shares authorized at March 31, 2026 and December 31, 2025; 115,893,943 shares issued and outstanding at March 31, 2026 and 114,793,067 shares issued and outstanding at December 31, 2025 | 1 | 1 |
| Additional paid-in capital | 1,508,643 | 1,486,229 |
| Accumulated deficit | (1,005,871) | (847,546) |
| Accumulated other comprehensive loss | (856) | 378 |
| Total stockholders’ equity | 501,917 | 639,062 |
| Total liabilities and stockholders’ equity | $608,242 | $715,729 |
Item 1. Financial Statements
FAQ
- What is Viking Therapeutics's total liabilities & equity?
- Viking Therapeutics (VKTX) reported total liabilities & equity of $608.24M in Q1 2026.
- How has Viking Therapeutics's total liabilities & equity changed year-over-year?
- Viking Therapeutics's total liabilities & equity decreased by 29.8% year-over-year, from $866.99M to $608.24M.
- What is the long-term trend for Viking Therapeutics's total liabilities & equity?
- Over 5 years (2020 to 2025), Viking Therapeutics's total liabilities & equity has grown at a 22.8% compound annual growth rate (CAGR), from $256.5M to $715.73M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Viking Therapeutics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude